UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 5, 2023 4:00 P.M.
Form:
F-1
CIK:
0001875091
Company Name:
NeuroSense Therapeutics Ltd.
File Number:
333-273375